Evercyte Showcases Expertise in Japan’s Pharma Landscape
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our
22
11, 2023
27
10, 2023
Participation to the first MOVE symposium
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, Austria We participated to the first MOVE
19
09, 2023
Participation to the Small New World 2.0 meeting
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
4
08, 2023
RPTEC/TERT1 relevant kidney-on-a-chip model
Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with
4
05, 2023
Participation in the CHANGE project
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on
4
04, 2023
Wharton’s jelly MSC-EVs
Recent publication showcasing our telomerized Wharton's jelly-MSCs as EV-cell factories April 4th, 2023, Vienna, AustriaOur telomerized Wharton's jelly-derived MSCs (WJ-MSC/TERT273)
30
11, 2022
The LifeSaver project film
The LifeSaver project film November 30, 2022, Vienna, Austria Evercyte is a proud participant in the LifeSaver Project